These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23196602)

  • 1. [New clinical entity of myasthenia gravis with autoimmune targets of heart and skeletal muscles].
    Suzuki S
    Rinsho Shinkeigaku; 2012; 52(11):1312-4. PubMed ID: 23196602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune targets of heart and skeletal muscles in myasthenia gravis.
    Suzuki S; Utsugisawa K; Yoshikawa H; Motomura M; Matsubara S; Yokoyama K; Nagane Y; Maruta T; Satoh T; Sato H; Kuwana M; Suzuki N
    Arch Neurol; 2009 Nov; 66(11):1334-8. PubMed ID: 19752287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and/or myocarditis.
    Kufukihara K; Watanabe Y; Inagaki T; Takamatsu K; Nakane S; Nakahara J; Ando Y; Suzuki S
    Sci Rep; 2019 Mar; 9(1):5284. PubMed ID: 30918333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance].
    Suzuki S
    Brain Nerve; 2011 Jul; 63(7):705-12. PubMed ID: 21747140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A patient with giant cell myocarditis and myositis associated with thymoma and myasthenia gravis].
    Sato H; Iwasaki E; Nogawa S; Suzuki S; Amano T; Fukuuchi Y; Shimoda M; Okada Y
    Rinsho Shinkeigaku; 2003 Aug; 43(8):496-9. PubMed ID: 14658403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
    Romi F; Skeie GO; Gilhus NE; Aarli JA
    Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel autoantibodies to a voltage-gated potassium channel Kv1.4 in a severe form of myasthenia gravis.
    Suzuki S; Satoh T; Yasuoka H; Hamaguchi Y; Tanaka K; Kawakami Y; Suzuki N; Kuwana M
    J Neuroimmunol; 2005 Dec; 170(1-2):141-9. PubMed ID: 16182377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of myasthenia gravis based on autoantibody status.
    Suzuki S; Utsugisawa K; Nagane Y; Satoh T; Terayama Y; Suzuki N; Kuwana M
    Arch Neurol; 2007 Aug; 64(8):1121-4. PubMed ID: 17698702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of late-onset, thymoma-associated myasthenia gravis with ryanodine receptor and titin antibodies and concomitant granulomatous myositis.
    Stefanou MI; Komorowski L; Kade S; Bornemann A; Ziemann U; Synofzik M
    BMC Neurol; 2016 Sep; 16(1):172. PubMed ID: 27623618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two cases of myasthenic syndrome with thymoma, polymyositis, myocarditis, and thyroiditis].
    Reznik M
    J Neurol Sci; 1974 Jul; 22(3):341-51. PubMed ID: 4836661
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
    Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
    Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart muscle antibodies in myasthenia gravis.
    Mygland A; Aarli JA; Hofstad H; Gilhus NE
    Autoimmunity; 1991; 10(4):263-7. PubMed ID: 1772962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis.
    Romi F; Suzuki S; Suzuki N; Petzold A; Plant GT; Gilhus NE
    J Neurol; 2012 Jul; 259(7):1312-6. PubMed ID: 22167224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nivolumab-induced Myositis and Myocarditis with Positive Anti-titin Antibody and Anti-voltage-gated Potassium Channel Kv1.4 Antibody.
    Ono R; Iwai Y; Yamazaki T; Takahashi H; Hori Y; Fukushima K; Saotome T
    Intern Med; 2022 Oct; 61(19):2973-2979. PubMed ID: 35314545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental thymitis, myocarditis and polymyositis. A contribution to the pathogenesis of myasthenia gravis Erb].
    Griss P; Fahr K
    Arch Kreislaufforsch; 1970; 63(3):257-65. PubMed ID: 4928860
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac involvements in myasthenia gravis associated with anti-Kv1.4 antibodies.
    Suzuki S; Baba A; Kaida K; Utsugisawa K; Kita Y; Tsugawa J; Ogawa G; Nagane Y; Kuwana M; Suzuki N
    Eur J Neurol; 2014 Feb; 21(2):223-30. PubMed ID: 23829303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle autoantibodies in subgroups of myasthenia gravis patients.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    J Neurol; 2000 May; 247(5):369-75. PubMed ID: 10896269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-striational antibodies detected in a patient with late-onset myasthenia gravis suffering from severe bradycardia: a case report].
    Fujita R; Matoba S; Morihata H; Inoue M
    Rinsho Shinkeigaku; 2021 Aug; 61(8):543-546. PubMed ID: 34275952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report of giant cell myocarditis and myositis observed during the clinical course of invasive thymoma associated with myasthenia gravis.
    Tanahashi N; Sato H; Nogawa S; Satoh T; Kawamura M; Shimoda M
    Keio J Med; 2004 Mar; 53(1):30-42. PubMed ID: 15096726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.